Prevention Of Parasuicide by Manual Assisted Cognitive-behavioural Therapy

Medical Research Council (MRC) (UK)0 个研究点目标入组 500 人开始时间: 2000年10月23日最近更新: 2015年1月13日

试验速览

暂无简介。

•Patients presenting to the psychiatric services at any of five centres:
•1. Southern General Hospital, Victoria Hospital and Stobhill Hospital in Glasgow
•2. Royal Edinburgh Hospital, Edinburgh
•3. Queen's Medical Centre, Nottingham
•4. Chelsea and Westminster Hospital and St Mary's Hospital, West London
•5. King's College Hospital, South London and Maidstone General Hospital, Kent
•Patients will be included if they satisfy the following criteria:
•1. Aged between 16 and 65
•2. Have presented to an Accident & Emergency department after an episode of deliberate self-harm
•3. They have had at least one other episode of deliberate self-harm previously
•4. They give informed consent
•Recruitment will take place over 20 months and randomisation of each patient will take place after all baseline assessments have been completed by the research assessor

•1. Patients who do not have sufficient knowledge of English to enable them to be assessed adequately and to understand the treatment manual
•2. Patients who are only temporary residents in the area concerned (e.g. foreign visitors, tertiary referrals with a permanent address elsewhere) who are unlikely to be available for follow-up (This does not necessarily include many people who are homeless but who come from the geographical area concerned; this group is at high risk of repeated episodes and constitutes around one in six of all parasuicide episodes and many will be included if they have established links in the geographical area)
•3. Those with a diagnosis within the organic (F00 to F09), alcohol/drug dependence (F10 to F19), schizophrenia group (F20 to F29) or bipolar affective disorder (F31) (using the International Classification of Diseases [ICD-10] coding)
•4. People who require psychiatric hospitalisation after their self-harm episode. Recruitment will take place over 20 months and randomisation of each patient will take place after all base-line assessments have been completed by the research assessor

发起方

Medical Research Council (MRC) (UK)